Carcinoembryonic Antigen (CEA) Market Share, Key Trends, Vendor Strategies, Application Analysis, Regional Outlook & Forecasts to 2022

Global carcinoembryonic antigen market is expected to reach USD 2.56 Billion by 2022. Constant technological advancements pertaining to the development of novel biomarkers which can be used in combination with other biomarkers is expected to boost usage rates over the forecast period. Furthermore, the increasing prevalence of cancer is expected to heighten the demand for effective diagnostic tools.

According to the WHO estimates in 2012, global cancer incidences were nearly 14.1 million, which include 6.7 million female patients and 7.4 million male patients. Increasing demand for minimally invasive diagnostics procedures is also expected to play a vital role in determining market growth.

Browse Detail Report With TOC @ http://www.hexareports.com/report/carcinoembryonic-antigen-cea-market-analysis-by-application-colorectal-pancreatic-ovarian-breast-thyroid-cancer-and-segment-forecasts-to-2022

Key advantages associated with minimally invasive diagnostics procedures include elevated patient satisfaction levels as they entail minor incision wounds. In addition, these procedures involve relatively lesser hospital stays and therefore, are economically viable and involve fewer post procedure complications.

Further key findings from the study suggest:

Colorectal cancer was one of the largest revenue generating application segment of the carcinoembryonic antigen market and was estimated at USD 639.65 million in 2014. Increasing prevalence of colorectal cancer and usage of carcinoembryonic antigen tests at various stages is one of the critical factors accounting for its large share. For instance, in 2012, new cases of colorectal cancer were estimated to be over 93,000 and death due to colorectal cancer is expected to be over 49,700 in the U.S alone.

Carcinoembryonic antigen based breast cancer diagnosis is identified as the most lucrative application segment of the market. The market is driven by factors such as growing number of female population above 50 years, growing demand for Hormone Replacement Therapy (HRT) and cosmetic surgeries. Moreover, growing patient awareness levels and the presence of favorable government initiatives are expected to improve treatment rates over the forecast period.

North America was the largest regional market in 2014 owing to, the presence of high incidence rates, presence of favorable reimbursement framework, and high consumer awareness levels coupled with relatively higher healthcare expenditure levels.

Request A Sample copy of This Report @ http://www.hexareports.com/sample/42595

Asia Pacific is anticipated to witness the most lucrative growth over the forecast period. The presence of untapped opportunities, constantly improving healthcare infrastructure, economic development, and improving patient awareness levels are some factors accounting for this rapid growth.

Key players operating in carcinoembryonic antigen market include Abbott Diagnostics, Quest Diagnostics, Roche Diagnostics, GenWay Biotech Inc. and Correlogic Systems, Inc.

For the purpose of this study, Grand View Research has segmented the carcinoembryonic antigen market on the basis of application, and region:

Carcinoembryonic Antigen Application Outlook (Revenue, USD Million, 2012 - 2022)

* Colorectal cancer

* Pancreatic cancer

* Ovarian cancer

* Breast cancer

* Thyroid cancer

* Others

Carcinoembryonic Antigen Regional Outlook (Revenue, USD Million, 2012 - 2022)

* North America

* U.S.

* Canada

* Europe

* Germany

* France

* Spain

* Asia Pacific

* China

* Japan

* India

* MEA

* South Africa

* Latin America

* Brazil

* Mexico

Table Of Content

Chapter 1 Methodology and Scope

1.1 Research Methodology

1.2 Research Scope & Assumptions

1.3 List of Data Sources

Chapter 2 Executive Summary

Chapter 3 Carcinoembryonic Antigen Industry Outlook

3.1 Market segmentation

3.2 Market size and growth prospects

3.3 Carcinoembryonic antigen - Market dynamics

3.4 Key Opportunities Prioritized

3.5 Industry analysis - Porter's

3.6 Carcinoembryonic Antigen - PESTEL Analysis

Browse All Biotechnology Market Research Related Reports @http://www.hexareports.com/category/biotechnology-market

Chapter 4 Carcinoembryonic Antigen Application Outlook

4.1 Carcinoembryonic antigen revenue share by application, 2014 & 2022

4.2 Colorectal cancer market

4.3 Pancreatic cancer

4.4 Ovarian cancer

4.5 Breast cancer

4.6 Thyroid cancer

4.7 Others

Chapter 5 Carcinoembryonic Antigen Regional Outlook

5.1 Carcinoembryonic antigen market share, by region, 2014 & 2022

5.2 North America

5.3 Europe

5.4 Asia Pacific

5.5 Latin America

5.6 MEA

Chapter 6 Competitive Landscape

6.1 Quest Diagnostics

6.2 Roche Diagnostics

6.3 Abbott Diagnostics

6.4 GenWay Biotech Inc.

6.5 Correlogic Systems, Inc.

Browse Full Report @ http://www.hexareports.com/report/carcinoembryonic-antigen-cea-market-analysis-by-application-colorectal-pancreatic-ovarian-breast-thyroid-cancer-and-segment-forecasts-to-2022

About Us:

Hexa Reports is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Felton Office Plaza, 

6265 Highway 9, 

Felton, California, 95018, 

United States

Phone Number

1-800-489-3075

Email Us: sales@hexareports.com

Website: http://www.hexareports.com/

Blood Gas And Electrolyte Analyzers Market Share, Key Trends, Vendor Strategies, Application Analysis, Regional Outlook & Forecasts to 2022

Global blood gas and electrolyte market is expected to reach USD 653.5 million by 2022. Rising number of patients in ICU and critical care units and increasing demand for high throughput and integrated systems are some key factors likely to drive the blood gas and electrolyte analyzers market. Growing global geriatric population base is also expected to significantly contribute towards market growth over the forecast period, by triggering the incidence rates of target diseases and widening the base of patients requiring critical care.

Furthermore, the emergence of multi-parameter monitoring devices owing to, expanding test menus and growing demand for portable devices is expected to boost usage rates over the forecast period. The availability of blood gas analyzers has helped enhance the care of critically ill patients allowing for frequent diagnosis and monitoring of respiratory problems and ability to guide prognosis and therapy.

Browse Detail Report With TOC @ http://www.hexareports.com/report/blood-gas-and-electrolyte-analyzers-market-analysis-by-product-benchtop-portable-by-application-blood-gas-analyzers-electrolyte-analyzers-combined-analyzers-by-end-use-clinical-laboratories-point-of-care-and-segment-forecasts-to-2022

Rising demand for technically advanced sleek handheld devices involving short turnaround time has resulted in the development of more compact, sleek, handheld point-of-care devices. For instance, the OPTI CCA-TS2 blood gas and electrolyte analyzers use innovative optical technology and provide fast results while requiring minimal maintenance.

Further key findings from the study suggest:

Portable analyzers dominated the market with a share of over 60.0% in 2014 and are also expected to witness lucrative growth over the forecast period. Growing demand for automated, self-monitoring, portable devices, shorter analysis time, and quick accurate results are key factors boosting the growth of this segment.

Combined blood gas and electrolyte analyzers are expected to rapidly gain market share over the forecast period. Rising need for analyzers, which can analyze blood and electrolyte samples together are swiftly gaining popularity among users.

North America accounted for more than 40% of the blood gas and electrolyte analyzers market in 2014. Presence of sophisticated healthcare infrastructure along with favorable reimbursement plans are some key factors expected to drive regional market growth.

Presence of high unmet needs clubbed with rapidly improving healthcare infrastructure in the emerging markets of India and China is expected to help Asia Pacific grow at a lucrative rate throughout the forecast period. Growing demand for decentralized point-of-care diagnostic facilities handling large volumes of diagnostic tests is also expected to drive regional market growth.

Request A Sample copy of This Report @ http://www.hexareports.com/sample/42586

Key players of the blood gas and electrolyte analyzers market include Siemens, Medica, Roche, Nova Stat, Bayer, Radiometer Medical, Convergent technologies, Dalko Diagnostics, Afford Medical Technologies, and Accurex Biomedical Pvt. Ltd.

For the purpose of this study, Grand View Research has segmented the blood gas and electrolyte analyzers market on the basis of products, application, end-use, and region:

Global Blood Gas and Electrolyte Analyzers Market, Product Outlook (Revenue, USD Million, 2012 - 2022)

* Benchtop

* Portable

Global Blood Gas and Electrolyte Analyzers Market, Application Outlook (Revenue, USD Million, 2012 - 2022)

* Blood gas analyzers

* Electrolyte analyzers

* Combined analyzers

Global Blood Gas and Electrolyte Analyzers Market, End-use Outlook (Revenue, USD Million, 2012 - 2022)

* Clinical laboratories

* Point-of-care

Table Of Content

Chapter 1 Methodology and Scope

1.1 Research Methodology

1.2 Research Scope & Assumptions

1.3 List of Data Sources

Chapter 2 Executive Summary

Chapter 3 Blood Gas And Electrolyte Analyzers Industry Outlook

3.1 Market Segmentation

3.2 Market size and growth prospects

3.3 Blood gas and electrolyte analyzers - Market dynamics

3.4 Key Opportunities Prioritized

3.5 Industry Analysis - Porter's

3.6 Blood gas and electrolyte analyzers - PESTEL Analysis

3.7 Global blood gas and electrolyte analyzers - Value chain analysis

Chapter 4 Blood Gas and Electrolyte Analyzers Product outlook

4.1 Blood gas and electrolyte analyzers market share by product, 2014 & 2022

4.2 Benchtop blood gas and electrolyte analyzers

Browse All Medical Devices Market Research Related Reports @http://www.hexareports.com/category/medical-devices-market

Chapter 5 Blood Gas and Electrolyte Analyzers Application Outlook

5.1 Blood gas and electrolyte analyzers revenue share by application, 2014 & 2022

5.2 Blood gas analyzers market

5.3 Blood gas analyzers market, 2012 - 2022 (USD Million)

5.4 Electrolyte analyzers market

5.5 Electrolyte analyzers market, 2012 - 2022 (USD Million)

5.6 Combined analyzers

Chapter 6 Blood Gas and Electrolyte Analyzers Market End-use Outlook

6.1 Blood gas and electrolyte analyzers revenue share by end-use, 2014 & 2022

6.2 Central laboratories market

6.3 Point-of-care market

Chapter 7 Blood Gas and Electrolyte Analyzers Regional Outlook

7.1 Blood gas and electrolyte analyzers market share, by region, 2014 & 2022

7.2 North America

7.3 Europe

7.4 Asia Pacific

7.5 Latin America

7.6 MEA

Chapter 8 Competitive Landscape

8.1 Siemens

8.2 Medica

8.3 Roche

8.4 Erba

8.5 Nova Stat

8.6 Bayer

Browse Full Report @ http://www.hexareports.com/report/blood-gas-and-electrolyte-analyzers-market-analysis-by-product-benchtop-portable-by-application-blood-gas-analyzers-electrolyte-analyzers-combined-analyzers-by-end-use-clinical-laboratories-point-of-care-and-segment-forecasts-to-2022

About Us:

Hexa Reports is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Felton Office Plaza, 

6265 Highway 9, 

Felton, California, 95018, 

United States

Phone Number

1-800-489-3075

Email Us: sales@hexareports.com

Website: http://www.hexareports.com/

Animal Health Market Global share, Size, Trends and price, Competitive Scenario And Forecasts 2015-2019

Animal healthcare refers to guarding, preserving, and providing veterinary services to animals to enhance their quality of life, increase their lifespan, and increase yield. Animal healthcare is provided using pharmaceuticals, feed additives, and biologicals. Animal pharmaceuticals consist of parasiticides, anti-infective products, tablets, and other pharmaceuticals used to treat or prevent diseases in animals.

Animal feed additives improve the quality of animal food, thereby improving the health of animals. Animal biologicals are vaccines, immunostimulants, allergens, bacterins, antibodies, antitoxins, toxoids, and antigenic or immunizing components of microorganisms, used in the prevention, diagnosis, and treatment of diseases in animals. These products can be natural or synthetic in origin.

Browse Detail Report With TOC @ http://www.hexareports.com/report/global-animal-health-market-2015-2019

Technavio's analysts forecast the global animal health market to grow at a CAGR of 3.96% over the period 2014-2019.

Covered in this report

The report covers the current scenario and the growth prospects of the global animal health market for the period of 2015-2019. To calculate the market size, the report considers revenue generated through sales of various healthcare products for animals, including:

* Biologicals

* Feed additives

* Pharmaceuticals

Based on species, the market is divided into the following:

* Commercial animals

* Companion animals

Technavio's report, Global Animal Health Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers APAC, Europe, Latin America, MEA, and North America; it also covers the global animal health market landscape and its growth prospects in the coming years. The report also includes a discussion on the Key vendors operating in this market.

Key regions

* APAC

* Europe

* Latin America

* MEA

* North America

Key vendors

* Bayer

* Elanco

* Merck

* Merial

* Zoetis

Request A Sample copy of This Report @ http://www.hexareports.com/sample/47541

Other prominent vendors

* Biogenesis Bago

* Boehringer Ingelheim

* Ceva Sante Animale

* Heska

* LogiXML

* Lohmann Animal Health International

* Neogen

* Novartis

* Thermo Fisher Scientific

* Vetoquinol

* Virbac

Market driver

* Increase in consumption of meat and milk

* For a full, detailed list, view our report

Market challenge

* Genetic erosion

* For a full, detailed list, view our report

Market trend

* Increase in M&A

* For a full, detailed list, view our report

Key questions answered in this report

1. What will the market size be in 2019 and what will the growth rate be?

2. What are the key Market trends?

3. What is driving this market?

4. What are the challenges to market growth?

5. Who are the Key vendors in this market space?

6. What are the market opportunities and threats faced by the Key vendors?

7. What are the strengths and weaknesses of the Key vendors?

Table Of Content

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

Browse All Pharmaceutical Market Research Related Reports @http://www.hexareports.com/category/pharmaceutical-market

PART 04: Introduction

Key market highlights

PART 05: Market landscape

Market overview

Market size and forecast

Five forces analysis

PART 06: Market segmentation by animal type

Market segmentation by animal type

Global commercial animal health market

Global companion animal health market

PART 07: Market segmentation by products

Segmentation of the global animal health market by product

Global animal pharmaceuticals market

Global animal biologicals market

Global animal medicinal feed additives market

PART 08: Geographical segmentation

Global animal health market by geographical segmentation

Animal health market in North America

Animal health market in Europe

Animal health market in APAC

Animal health market in Latin America

Animal health market in MEA

Browse Full Report @ http://www.hexareports.com/report/global-animal-health-market-2015-2019

About Us:

Hexa Reports is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Felton Office Plaza, 

6265 Highway 9, 

Felton, California, 95018, 

United States

Phone Number

1-800-489-3075

Email Us: sales@hexareports.com

Website: http://www.hexareports.com/

Femtosecond Lasers for Cataract Surgery Market Shares, Strategies, and Forecasts, Worldwide, Nanotechnology, 2013 to 2019

WinterGreen Research announces that it has published a new study Femtosecond Lasers for Cataract Surgery Market Shares, Strategy, and Forecasts, Worldwide, 2013 to 2019. The 2013 study has 301 pages, 78 tables and figures. Worldwide markets are poised to achieve continuing growth as the aging population worldwide develops cataracts and need surgery. All older people develop cataracts, femtosecond lasers for cataract surgery improve the quality of the surgery in a dramatic manner. Femtosecond laser technology for cataract surgery represents a paradigm shift.

Browse Detail Report With TOC @ http://www.hexareports.com/report/femtosecond-lasers-for-cataract-surgery-market

Surgeons approach cataract surgery with the ability to use automated process that is more reliable and more repeatable than manual techniques previously available. Alcon LenSx femtosecond lasers increase precision for key manual steps of the cataract surgery procedure. This femtosecond laser cataract surgical system equipment makes it possible to deliver reproducible, predictable, and improved clinical outcomes for cataract surgery. Through image-guided visualization and micron-level laser precision, the surgeon has complete control over the surgery process.

Femtosecond laser cataract surgical systems offer an improved patient safety profile. Because of the simultaneous change in demographics and the introduction of automated process, ophthalmologists are facing an explosion in demand for their services the next 20 years. The aging of the baby boomers and the fact that patients older than 65 consume 10 times the eye care of patients younger than 65 creates unprecedented demand for cataract surgery. Cataracts are a clouding of the eye's natural lens that impairs one's ability to see clearly. With two accommodating Intraocular Lens IOLs likely to be approved within the next 12 months, the premium market is again exciting.

Cataract surgical technology is evolving rapidly. Laser-assisted cataract surgery technology is gaining traction with clinicians. Surgeons are getting trained in the techniques needed to perform surgeries using these new types of equipment. The motivation to learn the new surgical techniques is that the equipment comes with the promise of improved surgical precision. Ultrasonic phacoemulsification, the standard of care in cataract removal equipment for four decades, has been in great part responsible for the safety and effectiveness of modern cataract surgery. It is certain to remain the dominant lens removal technology in the near term.

A technology still in its infancy, laser-assisted cataract surgery using femtosecond lasers and picosecond lasers, promises to raise the standard of precision and safety to new heights. Numerous types, and styles of Intraocular Lenses (IOLs), varying in size, and attachment mechanisms compliment the introduction of the femtosecond laser cataract surgical systems. Cataract procedures for eye care have improved in accuracy as femtosecond laser-assisted surgery is introduced. Cataract surgery changes are documented in clinical trial and papers. Presentations have provided statistical proof of the potential of the new technology.

Request A Sample copy of This Report @ http://www.hexareports.com/sample/35377

The research proving effectiveness is of a breakthrough proportion. Precision, control, and efficacy of femtosecond lasers have exceeded manual incisional techniques faster than was anticipated. Patient populations have significant demand for improved visions as they age. Much of the over 65 population eludes the term elderly as people still remain active into their 70's, 80's and 90's thanks to health clubs and lifestyle changes including lots of exercise and healthy eating. The over 65 and elderly population segment is soaring. Life expectancies are climbing, and extended careers are becoming the norm.

As a result, growing needs and expectations for good vision in all ranges have created significant new market opportunities, expanding demand for multifocal and accommodating laser surgery. Surgeries are position to correct presbyopia, aspheric optics that address spherical aberration and make vision sharper, and support phakic IOLs allowing treatment of extreme refractive error. Femtosecond lasers for cataract surgery market driving forces include the aging of the population. With age, all people have cataracts which can be cured with IOL. There is an ever-increasing baby boom aging population. There is a growing precision of cataract surgery. Safety of cataract surgical medical devices and lenses are primary market concerns.

Table Of Content

1. Femtosecond Lasers for Cataract Surgery Market Description and Market Dynamics

1.1 Cataract Surgical Technology Is Evolving Rapidly

1.2 Femtosecond Lasers

1.3 World Economy Undergoing A Transformation

 

2. Femtosecond Lasers for Cataract Surgery Market Shares and Forecasts

2.1 Femtosecond Laser Cataract Surgical System Market Driving Forces

2.2 Femtosecond Laser Cataract Surgical System Market Shares

2.3 Femtosecond Laser Cataract Surgical System Market Forecasts

2.4 Femtosecond Laser Cataract Surgical System Prices

2.5 Femtosecond Laser Cataract Surgical System Regional Market Segments

3. Cataract Surgery Femtosecond Laser Product Description

3.1 Alcon Surgical LenSx® Laser

3.2 Bausch + Lomb and Technolas™ Perfect Vision

3.3 Abbott Medical Optics

3.4 Carl Zeiss VisuMax

3.5 MEL 80 Excimer Laser

Browse All Surgical Equipment Market Research Related Reports @http://www.hexareports.com/category/surgical-equipment-market

4. Femtosecond Lasers for Cataract Surgery Technology

4.1 Opportunity To Further Improve The Outcomes Of Cataract Surgery

4.2 Femtosecond Laser Application To Cataract Surgery Innovation

4.3 Abbott Femtosecond Laser Garners FDA Clearance For Cataract Surgery

4.4 LensAR Laser Cataract Surgery System

4.5 Cataract Incision

4.6 Astigmatism Correction at the Time of Cataract Surgery

4.7 FDA Status of Laser Cataract Surgery Systems in the United States

4.8 Cataract Surgery Most Common Surgical Procedure

4.9 Advantages of Calmar Fiber Lasers

4.10 The Human Eye

5. Femtosecond Laser for Cataract Surgery Company Description

5.1 Selected Developers of Laser Cataract Surgical Systems

5.2 20/10 Perfect Vision AG

5.3 Abbott Laboratories

5.4 AISIN / IMRA Femtolite F / H Family

5.5 Bioptigen

5.6 Biovision

5.7 Calmar Laser

5.8 Novartis Group / Alcon

5.9 Ophtec Artisan R

5.10 OptiMedica

Browse Full Report @ http://www.hexareports.com/report/femtosecond-lasers-for-cataract-surgery-market

About Us:

Hexa Reports is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Felton Office Plaza, 

6265 Highway 9, 

Felton, California, 95018, 

United States

Phone Number

1-800-489-3075

Email Us: sales@hexareports.com

Website: http://www.hexareports.com/

Computed Tomography (CT) Market Shares, Strategies, and Forecasts, Worldwide, 2013 to 2018

WinterGreen Research announces that it has published a new study Computed Tomography (CT) Market Shares, Strategy, and Forecasts, Worldwide, 2013 to 2018. The 2013 study has 412 pages, 185 tables and figures. Worldwide markets are poised to achieve continuing growth as CT gains significant new imaging clarity. CT imaging is useful for healthcare therapeutic decision-making. Infarctions caused by stroke and extensive bleeding are types of conditions imaged.

Browse Detail Report With TOC @ http://www.hexareports.com/report/computed-tomography-ct-market-shares-strategies-and-forecasts-worldwide-2013-to-2018

Subarachnoid hemorrhage and a ruptured aneurysm are imaged. Seeing the conditions clearly makes a huge difference in choosing between different treatment options. CT is a primary diagnostic tool in oncology. It is used to detect cancer, for oncologic treatment follow-up and in assessing the lung diseases. In emergency care, CT has become the primary test for trauma, stroke or chest pain. According to Susan Eustis, lead author of the study, "Superior image quality brings clinical improvement. Physicians are thrilled when they can see what is going on so much more clearly.

Market leaders in the higher-slice segments have proven superior image quality. They have pressure to prove they can incorporate effective dose-reduction techniques while maintaining image quality. High end imaging modalities require advanced image management and archival systems. The diagnostic outcome of molecular imaging is made available to clinicians. Healthcare IT and molecular imaging exploit the advantage of systems. Effective distribution of images to clinicians is needed. Integration with electronic medical records is critical."

This growth is driven in part by the growing popularity of independent diagnostic centers, which are increasing in number due to patient demand and the relatively low set-up cost compared to a full, multi-disciplinary hospital. Other drivers of growth include the increasing demands from governments for high quality healthcare delivery that is supported with CT imaging. Significant advances in imaging technologies promise to improve wellness through earlier and more accurate detection of medical conditions. Aging population and increase in the chronic disease, congestive heart failure and diabetes in the population are considered as the main drivers of the imaging market in the developed nations.

Obesity and use of statins are primary drives of chronic diseases. Lack of exercise and lack of good nutrition are underlying causes of obesity. A rising fiscal deficit is expected to inhibit the growth of CT in the developed nations. CT scans help physicians determine whether curative or palliative treatment is the best course of treatment. CT works for patients for esophageal cancer. The CT market is shaped by instruments capable of high scanning speed. High scanning speed reduces examination time and radiation exposure for patients.

Request A Sample copy of This Report @ http://www.hexareports.com/sample/35403

CT is useful for managing increasing rates of cardiovascular disease and cancer. In the face of a population explosion worldwide demand for healthcare has created a need for screening and early diagnosis of cardiovascular disease and cancer conditions. CT imaging radiation dose continues to be an area of concern. The industry continues to try to reduce exposure while ensuring image quality. Recent studies have centered on the correct dose for children and the obese. Worldwide, research is going to improve the current technology of CT.

Two topics are the focus of clinical research: reduced radiation, and evaluation of the hemodynamic significance of coronary stenosis. Growth comes as more emphasis is put on early diagnosis and prevention of disease. Heart failure patients can benefit from better imaging. Computed tomography scanner markets are driven by the trend towards multi-slice scanners, the global market for computed tomography scanners is expected to post a modest growth rate. The global market for CT scanners was valued at $3.7 billion in 2012. Total market value is expected to reach $6 billion by 2019.

Table Of Content

1. Computed Tomography (CT) Market Description and Market Dynamics

1.1 CT Dynamics

1.2 CT Produces A Volume Of Data

1.3 PPACA Imaging Provisions: Contiguous Body Part Reduction and Change in Utilization Assumption

1.4 Leading Causes of Death in US

1.5 US Total Number Of Procedures Performed

1.6 The Rules Of CT Imaging Have Changed

1.7 Spatial Resolution

1.8 GE Healthcare Veo Low Dose Model-Based Iterative Reconstruction Product

1.9 Computed Tomography Care Settings

1.10 World Economy Undergoing A Transformation

2. Computed Tomography (CT) Market Shares and Forecasts

2.1 Computed Tomography CT Market Driving Forces

2.2 Computed Tomography CT Market Shares

2.3 Computed Tomography CT Scanner Market Forecasts

2.4 Global Diagnostic Imaging Market

2.5 CT Scanning ROI

2.6 Computed Tomography CT Scanner Prices

2.7 CMS CT Payment Revisions

2.8 CT Applications

2.9 Computed Tomography CT Scanner Regional Market Analysis

Browse All ICT Market Research Related Reports @http://www.hexareports.com/category/ict-market

3. Computed Tomography (CT) Product Description

3.1 GE

3.2 Siemens Computed Tomography

3.3 Philips Computed Tomography

3.4 Toshiba Aquilion CT Computed Tomography

3.5 Hitachi CT

3.6 Pie Medical Imaging CT Modules

3.7 Analogic Computed Tomography Equipment Technology for OEMs

3.8 Shimadzu

3.9 Neusoft Medical

3.10 OptiMedica

4. Computed Tomography (CT) Technology

4.1 Medical Imaging Markets: Contrast Agents

4.2 CT in Pediatrics

4.3 CT for Oncology

4.4 Pulmonary Embolism

4.5 CPT Codes for 3D Rendering Services

4.6 Costs For PET And PET/CT

4.7 Reimbursement Decisions Require Assessment Of Economic Benefit

4.8 Issues in International Health Policy

4.9 IBM Watson

5. Computed Tomography (CT) Company Description

5.1 Acceleware

5.2 Analogic

5.3 Barco NV

5.4 Esaote Group

5.5 GE Healthcare

5.6 Hitachi

5.7 Neurologica Corp.

5.8 Neusoft Medical Systems

5.9 OptiMedica

5.10 Philips

Browse Full Report @ http://www.hexareports.com/report/computed-tomography-ct-market-shares-strategies-and-forecasts-worldwide-2013-to-2018

About Us:

Hexa Reports is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Felton Office Plaza, 

6265 Highway 9, 

Felton, California, 95018, 

United States

Phone Number

1-800-489-3075

Email Us: sales@hexareports.com

Website: http://www.hexareports.com/

Cardiac Event Ambulatory Monitors and Recorders Market Shares, Strategies, and Forecasts, Worldwide, 2013 to 2018

WinterGreen Research announces that it has published a new study Cardiac Event Ambulatory Monitors and Recorders Market, Shares, Strategies, and Forecasts, Worldwide, 2013 to 2018. The 2013 study has 316 pages, 101 tables and figures. Worldwide markets are poised to achieve significant growth as event recorders find ways to support lowering the cost of care delivery by supporting shorter hospital stays and more home based services.

New markets in clinical diagnoses and clinical studies are emerging as prices decrease and technology creates more advanced devices. Smart phones include the technology to implement a core device used for m-health implementations. Unit functions are being extended from direct arrhythmia symptom analysis to sleep studies and clinical drug efficacy studies creating significant growth opportunity.

Browse Detail Report With TOC @ http://www.hexareports.com/report/cardiac-event-ambulatory-monitors-and-recorders-market-shares-strategies-and-forecasts-worldwide-2013-to-2018

According to Susan Eustis, lead author of the WinterGreen Research team that prepared the cardiac event ambulatory monitors and recorders market research study, "Shortness of breath is a common symptom of cardiac disease. It is frequently misdiagnosed as a respiratory symptom or ignored by patients and is not even considered a cardiac symptom when the clinician is making a diagnosis. Cardiac event ambulatory monitors can detect arrhythmias and get people to treatment faster before it is too late to correct congestive heart failure."

Early treatment is essential and the technology is a vital aid in providing that treatment. Hospitals and clinicians will have increased access to devices as insurers realize the value of detecting and treating cardiac disease early. Sleep studies and clinical drug efficacy study opportunities are creating significant growth opportunity.

Cardiac Event Recording and monitors are evolving as a services industry. Patients do not pay directly for units, they are provided by a clinician and the clinician is reimbursed by CMS in the US as a fee for service. In this manner the vendors participate in the services market. The cardiac event recording services industry is fragmented and characterized by a large number of smaller regional hospital and home care service providers.

Consideration of Cardiac Event Recorder Market Forecasts indicates that markets at $197.8 million in 2012 will reach $862.7 million by 2018. Growth comes as more emphasis is put on early diagnosis and prevention of disease. Heart failure patients participating in home based programs get called back from nurse within 20 minutes of transmitting readings. This is similar to the response time available in a hospital and positions products in the large and growing telemedicine market space.

Request A Sample copy of This Report @ http://www.hexareports.com/sample/35405

For a patient that has arrhythmia and a device detects symptoms, there is the ability to take life saving action. Quick response brings the matter to the attention of the clinician often without patient involvement, helping better serve the patient. Advice can be rendered as to how and why weight fluctuation is a issue and how control of disease is based on lifestyle and diet. Rapid weight gain can indicate fluid retention and a worsening of cardiac function.

This study illustrates the cardiac event recording market driving forces and provides the market shares and consideration of market size and number of recorders prescribed or used. It describes monitoring services used and services provided to subscribers, reimbursement by insurance carriers. The principal competitive factors that impact the success of cardiac monitoring solutions are addressed in the comprehensive market study:

WinterGreen Research is an independent research organization funded by the sale of market research studies all over the world and by the implementation of ROI models that are used to calculate the total cost of ownership of equipment, services, and software. The company has 35 distributors worldwide, including Global Information Info Shop, Market Research.com, Research and Markets, electronics.ca, Bloomberg, and Thompson Financial.

Table Of Content

1. Cardiac Event Monitoring Market Description and Market Dynamics

1.1 Cardiac Event Monitoring

1.2 Cardiac Event Monitors

1.3 Holter Monitors

1.4 Remote Monitoring as Standard of Care

1.5 Telemedicine

1.6 Telemonitors Customized To Meet Individual Needs

1.7 US Makes Telemedicine Priority

1.8 Tele-Monitor Devices

1.9 Telemonitoring Research

1.10 Physician Notification on CHF

2. Cardiac Event Ambulatory Monitors and Recorders: Market Shares and Forecasts

2.1 Cardiac Event Recording Market Driving Forces

2.2 Cardiac Event Recorder Market Shares

2.3 Cardiac Event Monitor Market Shares, Units and Dollars, Worldwide

2.4 Cardiac Event Recorder Market Forecasts

2.5 US Veterans Administration (VA) Tele-monitoring of Congestive Heart Failure (CHF)

2.6 Total Number Of Surgical Procedures And Market Penetration of Surgical Robots

2.7 Telemedicine Market Driving Forces

2.8 Cardiac Event Recording Pricing

2.9 Cardiac Event Recorder Regional Market Segments

Browse All Surgical Equipment Market Research Related Reports @ http://www.hexareports.com/category/surgical-equipment-market

3. Cardiac Event Ambulatory Monitors and Recorders: Product Description

3.1 Philips Event Recorder Monitors

3.2 CardioNet

3.3 Card Guard / Instromedix

3.4 eCardio

3.5 iRhythm / Zio® Event Card

3.6 Reka e100

3.7 Cardiac Event Recorder Services

3.8 Lifewatch Services

3.9 Defibrillator / Event Monitor Devices

4. Cardiac Event Monitor Technology

4.1 Cardiac Event Monitor Lead Placement

4.2 Reimbursement and Code Chart

4.3 Cardiac Event Recorder Validation and Use Cases

4.4 Event Monitoring Studies

4.5 Government Regulation

5. Cardiac Event Ambulatory Monitors and Recorders: Company Profiles

5.1 AT&T

5.2 Biotronik

5.3 Cardionet

5.4 eCardio

5.5 iRhythm / Zio

5.6 LifeLine Medical

5.7 Lifewatch

5.8 Philips

5.9 Reka

5.10 VRI

Browse Full Report @ http://www.hexareports.com/report/cardiac-event-ambulatory-monitors-and-recorders-market-shares-strategies-and-forecasts-worldwide-2013-to-2018

About Us:

Hexa Reports is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Felton Office Plaza, 

6265 Highway 9, 

Felton, California, 95018, 

United States

Phone Number

1-800-489-3075

Email Us: sales@hexareports.com

Website: http://www.hexareports.com/